fMRI Findings in Cortical Brain Networks Interactions in Migraine Following Repetitive Transcranial Magnetic Stimulation.
functional connectivity
headache
migraine
neuroimaging
neurostimulation
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2022
2022
Historique:
received:
07
04
2022
accepted:
12
05
2022
entrez:
8
7
2022
pubmed:
9
7
2022
medline:
9
7
2022
Statut:
epublish
Résumé
Repetitive transcranial magnetic stimulation (rTMS) is one of the high-potential non-pharmacological methods for migraine treatment. The purpose of this study is to define the neuroimaging markers associated with rTMS therapy in patients with migraine based on data from functional MRI (fMRI). A total of 19 patients with episodic migraine without aura underwent a 5-day course of rTMS of the fronto-temporo-parietal junction bilaterally, at 10 Hz frequency and 60% of motor threshold response of 900 pulses. Resting-state functional MRI (1.5 T) and a battery of tests were carried out for each patient to clarify their diagnosis, qualitative and quantitative characteristics of pain, and associated affective symptoms. Changes in functional connectivity (FC) in the brain's neural networks before and after the treatment were identified through independent components analysis. Over the course of therapy, we observed an increase in FC of the default mode network within it, with pain system components and with structures of the visual network. We also noted a decrease in FC of the salience network with sensorimotor and visual networks, as well as an increase in FC of the visual network. Besides, we identified 5 patients who did not have a positive response to one rTMS course after the first week of treatment according to the clinical scales results, presumably because of an increasing trend of depressive symptoms and neuroimaging criteria for depressive disorder. Our results show that a 5-day course of rTMS significantly alters the connectivity of brain networks associated with pain and antinociceptive brain systems in about 70% of cases, which may shed light on the neural mechanisms underlying migraine treatment with rTMS.
Sections du résumé
Background
UNASSIGNED
Repetitive transcranial magnetic stimulation (rTMS) is one of the high-potential non-pharmacological methods for migraine treatment. The purpose of this study is to define the neuroimaging markers associated with rTMS therapy in patients with migraine based on data from functional MRI (fMRI).
Materials and Methods
UNASSIGNED
A total of 19 patients with episodic migraine without aura underwent a 5-day course of rTMS of the fronto-temporo-parietal junction bilaterally, at 10 Hz frequency and 60% of motor threshold response of 900 pulses. Resting-state functional MRI (1.5 T) and a battery of tests were carried out for each patient to clarify their diagnosis, qualitative and quantitative characteristics of pain, and associated affective symptoms. Changes in functional connectivity (FC) in the brain's neural networks before and after the treatment were identified through independent components analysis.
Results
UNASSIGNED
Over the course of therapy, we observed an increase in FC of the default mode network within it, with pain system components and with structures of the visual network. We also noted a decrease in FC of the salience network with sensorimotor and visual networks, as well as an increase in FC of the visual network. Besides, we identified 5 patients who did not have a positive response to one rTMS course after the first week of treatment according to the clinical scales results, presumably because of an increasing trend of depressive symptoms and neuroimaging criteria for depressive disorder.
Conclusions
UNASSIGNED
Our results show that a 5-day course of rTMS significantly alters the connectivity of brain networks associated with pain and antinociceptive brain systems in about 70% of cases, which may shed light on the neural mechanisms underlying migraine treatment with rTMS.
Identifiants
pubmed: 35800086
doi: 10.3389/fneur.2022.915346
pmc: PMC9253380
doi:
Types de publication
Journal Article
Langues
eng
Pagination
915346Informations de copyright
Copyright © 2022 Markin, Trufanov, Frunza, Litvinenko, Tarumov, Krasichkov, Polyakova, Efimtsev and Medvedev.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Pain. 2020 Apr;161(4):856-864
pubmed: 31815918
Hum Brain Mapp. 2020 Apr 1;41(5):1362-1371
pubmed: 31789480
Sci Rep. 2021 May 5;11(1):9573
pubmed: 33953315
Headache. 2020 Jul;60(7):1228-1243
pubmed: 32533895
Cephalalgia. 2018 Oct;38(11):1731-1741
pubmed: 29237282
Cephalalgia. 2022 Apr;42(4-5):326-334
pubmed: 34579559
Neuron. 2018 Mar 7;97(5):1004-1021
pubmed: 29518355
Neuromodulation. 2020 Apr;23(3):267-290
pubmed: 32212288
Neurol Sci. 2021 Jan;42(1):131-139
pubmed: 32556749
Cephalalgia. 2016 Jan;36(1):53-66
pubmed: 25888585
Brain Sci. 2021 Feb 13;11(2):
pubmed: 33668449
Hum Brain Mapp. 1996;4(1):58-73
pubmed: 20408186
Lancet Neurol. 2015 Jan;14(1):81-91
pubmed: 25496899
Neuroimage. 2021 Jan 1;224:117449
pubmed: 33059054
Neuromodulation. 2020 Apr;23(3):366-372
pubmed: 31667947
Front Neurol. 2019 Dec 13;10:1325
pubmed: 31920945
Alzheimers Res Ther. 2020 Jan 6;12(1):9
pubmed: 31907068
J Headache Pain. 2020 Dec 2;21(1):137
pubmed: 33267788
Neurology. 2020 Feb 18;94(7):e741-e751
pubmed: 31964691
J Headache Pain. 2019 Nov 20;20(1):108
pubmed: 31747874
Aust N Z J Psychiatry. 2020 Jun;54(6):582-590
pubmed: 32419470
Headache. 2010 Jul;50(7):1153-63
pubmed: 20553334
Clin Psychopharmacol Neurosci. 2018 Feb 28;16(1):62-66
pubmed: 29397668
Brain. 2016 Jul;139(Pt 7):2002-14
pubmed: 27246325
J Clin Med. 2021 Jul 27;10(15):
pubmed: 34362086
Headache. 2017 Mar;57(3):517-524
pubmed: 28028801
eNeuro. 2017 Jan 17;3(6):
pubmed: 28101529
J Cereb Blood Flow Metab. 2019 Apr;39(4):650-669
pubmed: 29154684
Curr Neurol Neurosci Rep. 2017 Oct 23;17(12):95
pubmed: 29063211
Brain Connect. 2012;2(3):125-41
pubmed: 22642651
J Headache Pain. 2016 Dec;17(1):100
pubmed: 27778244
Pain Med. 2015 Sep;16(9):1827-34
pubmed: 26177612
J Headache Pain. 2016 Dec;17(1):98
pubmed: 27771875
Hum Brain Mapp. 2001 Nov;14(3):140-51
pubmed: 11559959
Cephalalgia. 2013 Jul;33(9):629-808
pubmed: 23771276
Lancet Neurol. 2018 Nov;17(11):954-976
pubmed: 30353868
Front Behav Neurosci. 2020 Oct 06;14:567588
pubmed: 33132860
J Pain Res. 2019 Apr 11;12:1155-1178
pubmed: 31114299
J Headache Pain. 2017 Aug 22;18(1):86
pubmed: 28831756